Myeloma patients may get a boost from diet and exercise program

NCT ID NCT07236502

First seen Jun 25, 2026 · Last updated Jul 23, 2026 · Updated 3 times

Summary

This study tests whether a 16-week lifestyle program focused on nutrition and physical activity can improve physical function, quality of life, and biological aging markers in people with multiple myeloma. About 184 participants will be randomly assigned to either start the program right away or wait 16 weeks. The program includes coaching on eating and exercise habits, with assessments of strength, balance, and blood biomarkers.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
diet and exercise program
What this could lead to
If it works, this could point toward a simple lifestyle program to help people with myeloma feel better and move better.
What could go wrong
This is a small, early-stage study with no blinding, so results may be influenced by participant expectations. The program requires significant commitment and may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA (MM) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Loyola University Chicago

    RECRUITING

    Maywood, Illinois, 60153, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Medical College of Wisconsin

    RECRUITING

    Milwaukee, Wisconsin, 53226, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.